These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 29483769)

  • 1. Asthma and poly(ADP-ribose) polymerase inhibition: a new therapeutic approach.
    Zaffini R; Gotte G; Menegazzi M
    Drug Des Devel Ther; 2018; 12():281-293. PubMed ID: 29483769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PARP is activated in human asthma and its inhibition by olaparib blocks house dust mite-induced disease in mice.
    Ghonim MA; Pyakurel K; Ibba SV; Wang J; Rodriguez P; Al-Khami AA; Lammi MR; Kim H; Zea AH; Davis C; Okpechi S; Wyczechowska D; Al-Ghareeb K; Mansy MS; Ochoa A; Naura AS; Boulares AH
    Clin Sci (Lond); 2015 Dec; 129(11):951-62. PubMed ID: 26205779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PARP inhibition treatment in a nonconventional experimental mouse model of chronic asthma.
    Zaffini R; Di Paola R; Cuzzocrea S; Menegazzi M
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1301-1313. PubMed ID: 27604227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(ADP-ribose) polymerase-1 inhibition prevents eosinophil recruitment by modulating Th2 cytokines in a murine model of allergic airway inflammation: a potential specific effect on IL-5.
    Oumouna M; Datta R; Oumouna-Benachour K; Suzuki Y; Hans C; Matthews K; Fallon K; Boulares H
    J Immunol; 2006 Nov; 177(9):6489-96. PubMed ID: 17056581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(ADP-ribose) polymerase inhibition with HYDAMTIQ reduces allergen-induced asthma-like reaction, bronchial hyper-reactivity and airway remodelling.
    Lucarini L; Pini A; Gerace E; Pellicciari R; Masini E; Moroni F
    J Cell Mol Med; 2014 Mar; 18(3):468-79. PubMed ID: 24444146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BuShenYiQi Formula strengthens Th1 response and suppresses Th2-Th17 responses in RSV-induced asthma exacerbated mice.
    Wang J; Wu J; Kong L; Nurahmat M; Chen M; Luo Q; Li B; Wu X; Dong J
    J Ethnopharmacol; 2014 May; 154(1):131-47. PubMed ID: 24704667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased poly(ADP-ribose) polymerase (PARP)-1 expression and activity are associated with inflammation but not goblet cell metaplasia in murine models of allergen-induced airway inflammation.
    Havranek T; Aujla PK; Nickola TJ; Rose MC; Scavo LM
    Exp Lung Res; 2010 Sep; 36(7):381-9. PubMed ID: 20715980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-allergen challenge inhibition of poly(ADP-ribose) polymerase harbors therapeutic potential for treatment of allergic airway inflammation.
    Naura AS; Hans CP; Zerfaoui M; You D; Cormier SA; Oumouna M; Boulares AH
    Clin Exp Allergy; 2008 May; 38(5):839-46. PubMed ID: 18261157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18β-Glycyrrhetinic acid, the major bioactive component of Glycyrrhizae Radix, attenuates airway inflammation by modulating Th2 cytokines, GATA-3, STAT6, and Foxp3 transcription factors in an asthmatic mouse model.
    Kim SH; Hong JH; Lee JE; Lee YC
    Environ Toxicol Pharmacol; 2017 Jun; 52():99-113. PubMed ID: 28410469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-17 regulation: an attractive therapeutic approach for asthma.
    Park SJ; Lee YC
    Respir Res; 2010 Jun; 11(1):78. PubMed ID: 20565710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(ADP-ribosyl)ation in asthma and other lung diseases.
    Virág L
    Pharmacol Res; 2005 Jul; 52(1):83-92. PubMed ID: 15911336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of poly(ADP-ribose) polymerase inhibition on inflammatory cell migration in a murine model of asthma.
    Virág L; Bai P; Bak I; Pacher P; Mabley JG; Liaudet L; Bakondi E; Gergely P; Kollai M; Szabó C
    Med Sci Monit; 2004 Mar; 10(3):BR77-83. PubMed ID: 14976461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ursolic acid, a potential PPARγ agonist, suppresses ovalbumin-induced airway inflammation and Penh by down-regulating IL-5, IL-13, and IL-17 in a mouse model of allergic asthma.
    Kim SH; Hong JH; Lee YC
    Eur J Pharmacol; 2013 Feb; 701(1-3):131-43. PubMed ID: 23201068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoregulatory Effects of Paeoniflorin Exerts Anti-asthmatic Effects via Modulation of the Th1/Th2 Equilibrium.
    Zhang T; Yang Z; Yang S; Du J; Wang S
    Inflammation; 2015 Dec; 38(6):2017-25. PubMed ID: 25971794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of poly(ADP-ribose) polymerase-1 suppresses hyperstretch-induced expression of inflammatory cytokines in vitro.
    Wang J; Liu L; Xia Y; Wu D
    Acta Biochim Biophys Sin (Shanghai); 2014 Jul; 46(7):556-64. PubMed ID: 24829399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly-ADP ribose polymerase-14 limits severity of allergic skin disease.
    Krishnamurthy P; Da-Silva-Arnold S; Turner MJ; Travers JB; Kaplan MH
    Immunology; 2017 Nov; 152(3):451-461. PubMed ID: 28653395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging drugs for asthma.
    Walsh GM
    Expert Opin Emerg Drugs; 2008 Dec; 13(4):643-53. PubMed ID: 19046132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly (ADP-ribose) polymerase 14 and its enzyme activity regulates T(H)2 differentiation and allergic airway disease.
    Mehrotra P; Hollenbeck A; Riley JP; Li F; Patel RJ; Akhtar N; Goenka S
    J Allergy Clin Immunol; 2013 Feb; 131(2):521-31.e1-12. PubMed ID: 22841009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altering the Th1/Th2 balance as a therapeutic strategy in asthmatic diseases.
    Ray A; Cohn L
    Curr Opin Investig Drugs; 2000 Dec; 1(4):442-8. PubMed ID: 11249697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of acute pulmonary and systemic inflammation by 1,7-dimethylxanthine.
    Geraets L; Haegens A; Weseler AR; Brauers K; Vernooy JH; Wouters EF; Bast A; Hageman GJ
    Eur J Pharmacol; 2010 Mar; 629(1-3):132-9. PubMed ID: 19962977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.